Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,180 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Shares of GameStop rallied as investors weighed improved profits, strategic shifts, and mounting retailer momentum. T...
A broad crypto rout drags BitMine Immersion Technologies and Strategy lower as Ethereum tumbles about 7% in 24 hours....
Emerging frontier AI models are changing how we spot flaws in crypto systems. This in-depth look explains what fronti...
Unlock the insights hidden in a 2026 earnings call transcript. This practical guide shows you how to extract signals,...
Bill Gates testified before lawmakers about his relationship with Jeffrey Epstein, calling the meetings a grave error...
LISC CEO Michael Pugh warns that housing costs outpace wages are widening the affordability gap. The charity-finance ...
AMD faces a pivotal test as the AI boom lifts data-center demand. Analysts debate whether it can become the next tril...
As AI accelerates, Microsoft reports robust AI-driven revenue while stock faces capex-related volatility. This piece ...
Retirees are increasingly aiming for dependable cash flow without depleting principal. A $850,000 portfolio that quie...
The Bank of England unveiled a more permissive stablecoin framework, removing caps on individual holdings and setting...
Treasury Secretary Scott Bessent pitched a bold growth plan: 3% GDP growth without higher inflation, anchored by AI-d...